FLUMAZENIL Drug Patent Profile
✉ Email this page to a colleague
When do Flumazenil patents expire, and what generic alternatives are available?
Flumazenil is a drug marketed by Baxter Hlthcare Corp, Dr Reddys, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Rising, Sagent Pharms, and Sandoz. and is included in nine NDAs.
The generic ingredient in FLUMAZENIL is flumazenil. There are four drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the flumazenil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flumazenil
A generic version of FLUMAZENIL was approved as flumazenil by BAXTER HLTHCARE CORP on October 12th, 2004.
Summary for FLUMAZENIL
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 136 |
Clinical Trials: | 48 |
Patent Applications: | 2,908 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FLUMAZENIL |
DailyMed Link: | FLUMAZENIL at DailyMed |
Recent Clinical Trials for FLUMAZENIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yonsei University | N/A |
Daegu Catholic University Medical Center | N/A |
Korea University Guro Hospital | Phase 4 |
Pharmacology for FLUMAZENIL
Drug Class | Benzodiazepine Antagonist |
Medical Subject Heading (MeSH) Categories for FLUMAZENIL
Anatomical Therapeutic Chemical (ATC) Classes for FLUMAZENIL
US Patents and Regulatory Information for FLUMAZENIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 076755-002 | Oct 12, 2004 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 077071-002 | May 3, 2005 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hikma | FLUMAZENIL | flumazenil | INJECTABLE;INJECTION | 076256-002 | Oct 12, 2004 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |